Page last updated: 2024-10-24

pantogab and Parkinson Disease, Secondary

pantogab has been researched along with Parkinson Disease, Secondary in 2 studies

pantogab: RN given refers to cpd without isomeric designation; synonym hopantenic acid refers to (R)-isomer; synonym pantogam refers to Ca salt (2:1), ((R)-isomer

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noda, S1
Watanabe, R1

Reviews

1 review available for pantogab and Parkinson Disease, Secondary

ArticleYear
[Delayed type malignant syndrome and Parkinson's syndrome due to tiapride, Reye-like syndrome induced by calcium hopantenate].
    Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2

    Topics: Animals; Antipsychotic Agents; Diagnosis, Differential; gamma-Aminobutyric Acid; Humans; Neuroleptic

1999

Other Studies

1 other study available for pantogab and Parkinson Disease, Secondary

ArticleYear
[Consciousness disorders in the aged due to therapeutic drugs].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Apr-10, Volume: 79, Issue:4

    Topics: Aged; Anemia; Cognition Disorders; Consciousness Disorders; Drug Interactions; Flunarizine; gamma-Am

1990